Apoptosis
Research Areas
Products Related to Apoptosis(675)
- GC79231RMC-4998 TFAPurity: >99.00%
RMC-4998 TFA is an orally active inhibitor targeting the active or GTP-bound state of the KRAS G12C mutant.
- GC79326Tirzepatide sodiumPurity: >98.00%
Tirzepatide sodium (LY3298176 sodium) is a dual glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-1 ( GLP-1 ) receptor agonist.
- GC79338PL120131 acetatePurity: >99.50%
PL120131 acetate is a PD-1 antagonist, can specifically blocking the interaction between PD-1 and PD-L1, thereby effectively inhibiting the PD-1-mediated apoptosis signaling pathway.
- GC79339Anti-CD160 Antibody (MAT 302)Purity: >97.00%
Anti-CD160 Antibody (MAT 302) (CL1-R2) is a human monoclonal antibody targeting CD160.
- GC79465STAT3-IN-52 hydrochloridePurity: >96.00%
STAT3-IN-52 hydrochloride is an orally active STAT3 inhibitor with a K i value of 2.42 μM.
- GC79473AT-051/43421517CAS: 1241957-37-8Purity: >99.50%
AT-051/43421517 is a cytoprotective agent and apoptosis inhibitor that binds to human phosphoglycerate kinase 1 ( hPgk1 ).
- GC79475MKK7-JNK activator 1CAS: 3100092-62-1Purity: >99.50%
MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator.
- GC79486Bacoside A (mixture)Purity: >98.00%
Bacoside A (mixture) is a mixture composed of Bacoside A3, Bacopaside II, Bacopaside X and Bacopasaponin C.
- GC79487(S)-VerapamilCAS: 36622-29-4Purity: >99.50%
(S)-Verapamil ((S)-(-)-Verapamil) is an orally active MRP1 (ABCC1) modulator with a K d value of 113 nM for hamster MRP1.
- GC79504(R)-VerapamilCAS: 38321-02-7Purity: >98.50%
(R)-Verapamil (Dexverapamil) is an optically enantiomer of the oral-active Verapamil.
- GC79577PFKFB4-IN-1CAS: 2664831-55-2Purity: >99.50%
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels.
- GC79757ALOX5 stabilizer-1 TFAPurity: >98.00%
ALOX5 stabilizer-1 TFA is an arachidonate 5-lipoxygenase ( ALOX5 ) stabilizer with a K d of 7.26 μM.
- GC79758PAI-1-IN-1CAS: 1247823-40-0Purity: >99.00%
PAI-1-IN-1 is an orally active and specific PAI-1 inhibitor with an IC 50 of <6.95 μM.
- GC79807RP-182 acetatePurity: >98.50%
RP-182 acetate is a synthetic immunomodulatory peptide that exerts anti-tumor effects by targeting the mannose receptor CD206 ( K d = 8 μM) on the surface of tumor-associated macrophages (TAMs).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79230 | BBO-11818 | 3029443-36-2 | >99.50% | |
BBO-11818 is an orally active, highly selective (relative to NRAS and HRAS ), non-covalent pan- KRAS inhibitor ( IC 50 =28-120 nM). | ||||
| GC79231 | RMC-4998 TFA | - | >99.00% | |
RMC-4998 TFA is an orally active inhibitor targeting the active or GTP-bound state of the KRAS G12C mutant. | ||||
| GC79326 | Tirzepatide sodium | - | >98.00% | |
Tirzepatide sodium (LY3298176 sodium) is a dual glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-1 ( GLP-1 ) receptor agonist. | ||||
| GC79337 | ZSTK3744 | - | >98.00% | |
ZSTK3744 is an aryl hydrocarbon receptor ( AhR ) agonist. | ||||
| GC79338 | PL120131 acetate | - | >99.50% | |
PL120131 acetate is a PD-1 antagonist, can specifically blocking the interaction between PD-1 and PD-L1, thereby effectively inhibiting the PD-1-mediated apoptosis signaling pathway. | ||||
| GC79339 | Anti-CD160 Antibody (MAT 302) | - | >97.00% | |
Anti-CD160 Antibody (MAT 302) (CL1-R2) is a human monoclonal antibody targeting CD160. | ||||
| GC79451 | JP-11646 | 1902983-63-4 | >98.50% | |
JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM). | ||||
| GC79463 | NGI-189 | 2763063-26-7 | >99.00% | |
NGI‑189 is a selective OST‑A inhibitor. | ||||
| GC79465 | STAT3-IN-52 hydrochloride | - | >96.00% | |
STAT3-IN-52 hydrochloride is an orally active STAT3 inhibitor with a K i value of 2.42 μM. | ||||
| GC79473 | AT-051/43421517 | 1241957-37-8 | >99.50% | |
AT-051/43421517 is a cytoprotective agent and apoptosis inhibitor that binds to human phosphoglycerate kinase 1 ( hPgk1 ). | ||||
| GC79474 | (E/Z)-ASK1-IN-4 | 324566-92-9 | >98.00% | |
(E/Z)-ASK1-IN-4 is an isomer of ASK1-IN-4. | ||||
| GC79475 | MKK7-JNK activator 1 | 3100092-62-1 | >99.50% | |
MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator. | ||||
| GC79486 | Bacoside A (mixture) | - | >98.00% | |
Bacoside A (mixture) is a mixture composed of Bacoside A3, Bacopaside II, Bacopaside X and Bacopasaponin C. | ||||
| GC79487 | (S)-Verapamil | 36622-29-4 | >99.50% | |
(S)-Verapamil ((S)-(-)-Verapamil) is an orally active MRP1 (ABCC1) modulator with a K d value of 113 nM for hamster MRP1. | ||||
| GC79504 | (R)-Verapamil | 38321-02-7 | >98.50% | |
(R)-Verapamil (Dexverapamil) is an optically enantiomer of the oral-active Verapamil. | ||||
| GC79519 | SKF-96365 | 162849-90-3 | >99.50% | |
SKF-96365 is a TRPC channel antagonist and store-operated calcium entry ( SOCE ) inhibitor. | ||||
| GC79549 | FJ9 | 873841-43-1 | >98.50% | |
FJ9 is a NHERF1/PDZ inhibitor with human NHERF1 PDZ1 IC 50 1540 μM, NHERF1 PDZ2 IC 50 160 μM, and Frizzled-7-Dishevelled PDZ complex K i 10 μM. | ||||
| GC79577 | PFKFB4-IN-1 | 2664831-55-2 | >99.50% | |
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels. | ||||
| GC79578 | PrCP-7414 | 1252037-41-4 | >99.50% | |
PrCP-7414 is a prolyl carboxypeptidase ( PRCP ) inhibitor. | ||||
| GC79709 | HK2-IN-4 | 2748366-80-3 | >99.50% | |
HK2-IN-4 is a selective hexokinase 2 ( HK2 ) inhibitor with an IC 50 value of 0.79 μM and a K d value of 0.41 μM. | ||||
| GC79757 | ALOX5 stabilizer-1 TFA | - | >98.00% | |
ALOX5 stabilizer-1 TFA is an arachidonate 5-lipoxygenase ( ALOX5 ) stabilizer with a K d of 7.26 μM. | ||||
| GC79758 | PAI-1-IN-1 | 1247823-40-0 | >99.00% | |
PAI-1-IN-1 is an orally active and specific PAI-1 inhibitor with an IC 50 of <6.95 μM. | ||||
| GC79806 | TKL002 | 3098518-95-4 | >98.00% | |
TKL002 is a blood-brain barrier-permeable inhibitor of the CTH/H 2 S/NF-κB/EMT signaling axis. | ||||
| GC79807 | RP-182 acetate | - | >98.50% | |
RP-182 acetate is a synthetic immunomodulatory peptide that exerts anti-tumor effects by targeting the mannose receptor CD206 ( K d = 8 μM) on the surface of tumor-associated macrophages (TAMs). | ||||
